BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced a collaboration with Pfizer Inc. and global charitable foundation Wellcome to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world.
Building on ongoing efforts to advance the role of diagnostics in tackling the challenge of antimicrobial resistance (AMR), this collaboration will survey existing diagnostic practices to highlight both benefits and gaps in diagnostic testing in AMR stewardship to improve and further advocate for patient care, clinical practice and health care economics.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
